Hsinchu, Taiwan

Hsueh-Fen Chen

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: General Biologicals Corporation. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hsueh-Fen Chen. Retrieved from https://idiyas.com/inventor/hsueh-fen-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hsueh-Fen Chen: Innovator in Antimicrobial Peptides

Introduction: Hsueh-Fen Chen is a prominent inventor based in Hsinchu, Taiwan. She has made significant contributions to the field of antimicrobial research. Her work focuses on developing innovative solutions for treating microbial infections.

Latest Patents: Hsueh-Fen Chen holds a patent for an antimicrobial peptide and method for treating microbial infection. This peptide is a derivative of the peptide P-113. The amino acid sequence of the antimicrobial peptide is SEQ ID NO: 4 or SEQ ID NO: 5, with the C-terminus being either modified with a NH or not. This innovation represents a crucial advancement in the fight against microbial infections.

Career Highlights: Hsueh-Fen Chen is associated with General Biologicals Corporation, where she applies her expertise in antimicrobial research. Her work has garnered attention for its potential impact on healthcare and infection control.

Collaborations: Hsueh-Fen Chen has collaborated with notable colleagues, including Wen-Chi Cheng and Ming-Sun Liu. These partnerships have contributed to the advancement of her research and the development of new antimicrobial solutions.

Conclusion: Hsueh-Fen Chen is a trailblazer in the field of antimicrobial peptides, with her innovative patent showcasing her dedication to improving health outcomes. Her contributions are vital in addressing microbial infections and enhancing treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…